認知症患者の5年生存率と死亡率を予測する: XGBoostを用いたデータ主導のアプローチ
PubMedで要約を見る
まとめ
この要約は機械生成です。この研究では,認知症患者の5年生存率を予測する eXtreme Gradient Boosting (XGBoost) モデルを開発しました. ナソガストリックチューブ挿入や慢性腎臓病などの主要な予測要因は,標的治療を導くために特定されました.
科学分野
- 高齢者医療
- 医療におけるデータサイエンス
- 予測分析
背景
- 認知症は患者の生存や 医療資源の配分に重大な課題をもたらします
- 認知症における死亡率の予測要因を特定することは 適切な介入に不可欠です
研究 の 目的
- 認知症患者の5年生存率を予測するための eXtreme Gradient Boosting (XGBoost) の回帰モデルを開発し,検証する.
- この集団における死亡率と生存率の重要な予測要因を特定する.
主な方法
- モデル開発と検証のために台湾の国民健康保険データセット (n=6,556) を利用した.
- 訓練,検証,テストのデータセットは80/10/10に分けられています.
- コモルディティと人口統計を含む24の変数を予測要素として選択し,パフォーマンスのハイパーパラメータを最適化しました.
主要な成果
- XGBoostモデルは,5年生存率を予測するために81. 86%の精度とAUCを達成しました.
- トップの予測因子には 鼻胃管挿入,慢性腎臓病,癌,肺疾患が含まれています
- 併発症は生存率の予測に大きく影響した.
結論
- 開発されたXGBoostモデルは,認知症患者の5年生存率を効果的に予測します.
- 特定された主要なリスク要因は,標的の臨床ケアと医療資源計画にインパクトを与える.
- 発見は高リスクの認知症患者の 積極的な管理戦略を支持しています
関連する概念動画
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
Building a Survival Tree
Constructing a...
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Survival Times Are Positively Skewed
Survival times often exhibit positive skewness, unlike the normal distribution assumed...
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
A Gran plot is used to predict the equivalence volume or endpoint of a potentiometric or acid-base titration without reaching the endpoint. Typically, titration data is collected as a function of the titrant's volume up to a point less than the equivalence volume and then transformed into a linear format. The straight line is extended to the x-axis, indicating the necessary titrant volume to achieve the equivalence point.
For potentiometric titration, the Gran plot is created by plotting...

